Skip to content

A Trial Examining the Treatment of Common Warts With Combination Liquid Nitrogen (LN2) and Cantharidin

A Randomized Clinical Trial Examining the Efficacy of Treatment of Cutaneous Verruca Vulgaris in Adult Patients With Combined Liquid Nitrogen Cryotherapy and Topically Applied Cantharidin

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01084824
Enrollment
70
Registered
2010-03-11
Start date
2007-06-30
Completion date
2008-09-30
Last updated
2010-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Verruca Vulgaris

Keywords

Warts, Verruca vulgaris, Liquid Nitrogen, Cantharidin, combination treatment

Brief summary

The purpose of the study was to see if liquid nitrogen, a commonly used treatment for warts, is more effective if it is used alone, or if it is more effective if combined with cantharidin, a topical treatment also commonly used for warts (verruca vulgaris).

Interventions

DRUGLiquid nitrogen and cantharidin

Liquid nitrogen applied to wart(s), then cantharidin 1% topical applied afterward.

DRUGLiquid nitrogen and topical placebo

Liquid nitrogen applied to wart(s), then placebo vehicle applied thereafter.

Sponsors

North Idaho Dermatology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

1. common warts on non-genital, non-facial skin 2. otherwise healthy 3. between 18-65 and able to give informed consent 4. capable of tolerating treatment

Exclusion criteria

1. Ill-health 2. Poor tolerance or sensitivity to treatments in study 3. \<18 years old; \>65 years old 4. verruca plana or condyloma acuminata 5. immunosuppression or immune dysfunction 6. significant peripheral vascular disease 7. significant sensitivity to cold 8. epidermodysplasia verruciformis 9. mosaiform warts or periungual warts

Design outcomes

Primary

MeasureTime frameDescription
Percentage of common warts cleared12 weeksPercentage of treated warts cleared with treatment, as measured with dermatoscopic examination, after 12 weeks.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026